Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Arnab Sengupta Arnab Sengupta @ArnabSengupta.202093
Sep 24, 2021 $70.00 +13.01% $61.94 X 86.99% 1
JS JS Pro
Sep 23, 2021 $52.31 -12.99% $60.12 X 87.01% 0
JS JS Pro
Sep 21, 2021 $50.81 -3.88% $52.86 X 96.12% 1
Rybkarybka Rybkarybka Merchant
Sep 21, 2021 $47.70 -9.76% $52.86 X 90.24% 0
Sep 15, 2021 $41.79 -4.85% $43.92 X 95.15% 0
AlexVel AlexVel Pro
Sep 8, 2021 $45.89 -1.29% $46.49 X 98.71% 2
JS JS Pro
Sep 3, 2021 $57.64 +14.82% $50.20 X 85.18% 0
Sep 3, 2021 Bullish $50.20 X 0
Aug 30, 2021 $54.72 +2.74% $53.26 X 97.26% 1
AlexVel AlexVel Pro
Aug 30, 2021 $56.42 +5.93% $53.26 X 94.07% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE